$1.870
-0.068 (-3.61%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KPTI Prediction & Forecast by Similar Chart Analysis
Alphio's KPTI stock price prediction model matches the current Karyopharm Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.84 (-1.82%). The 1-week path is $1.78 (-4.76%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Karyopharm Therapeutics Inc Stock?
Karyopharm Therapeutics Inc is not a good buy right now due to significant financial losses and declining revenues. The current price is $1.87, with a 1-year change of -72.42%. The company reported a net loss of $67 million for Q2 2026, which is a substantial increase from the previous year's loss of $37.25 million. Additionally, there is a liquidity risk with only $65.4 million in cash, expected to be exhausted by September 2026, posing a serious threat to its operational viability.
KPTI stock price ended at $1.87 on Friday, after losing -3.61%
Karyopharm Therapeutics Inc (KPTI) last closed at $1.87, losing -3.61%. These facts feed the 1-day and 1-week KPTI price prediction above.
Analyst Consensus
Karyopharm Therapeutics Inc (KPTI): 10 buy, 0 hold, 1 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Karyopharm Therapeutics Inc (KPTI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches KPTI, ranked by similarity.
Seasonality analysis for KPTI
Historically the probability of a positive August return for KPTI is 1.59%. May offers the highest probability of a positive month at 65.08%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KPTI
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $4.33 | $4.47 | $5.04 | +138.80% |
| Sep 2026 | $3.68 | $4.32 | $4.47 | +131.23% |
| Oct 2026 | $4.08 | $4.13 | $4.88 | +121.11% |
| Nov 2026 | $3.89 | $3.98 | $4.15 | +112.90% |
| Dec 2026 | $3.16 | $3.70 | $3.82 | +97.99% |
In 2026, Karyopharm Therapeutics Inc (KPTI) is projected to range from $3.16 to $5.04.
Karyopharm Therapeutics Inc 2026 monthly forecast
In Aug 2026, Karyopharm Therapeutics Inc is projected to average $4.47, with a low of $4.33 and high of $5.04.
In Sep 2026, Karyopharm Therapeutics Inc is projected to average $4.32, with a low of $3.68 and high of $4.47.
In Oct 2026, Karyopharm Therapeutics Inc is projected to average $4.13, with a low of $4.08 and high of $4.88.
In Nov 2026, Karyopharm Therapeutics Inc is projected to average $3.98, with a low of $3.89 and high of $4.15.
In Dec 2026, Karyopharm Therapeutics Inc is projected to average $3.70, with a low of $3.16 and high of $3.82.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.